Home | Publications | Medical Devices place holder
place holder place holder

Medical Devices

Japan Nephrology and Urology Devices Investment Opportunities

Analysis and Forecasts to 2012

Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   86
ISBN Number   not applicable
Product Code   GMD1157
Ask a question about this product?

Price £1,045.00

approximately: $1,603 | €1,229

Summary


Japan Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to Japan nephrology & urology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the nephrology & urology devices in Japan.

Scope

  • The report provides nephrology and urology devices information broken down into detailed categories and segments in Japan.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the nephrology and urology devices market in Japan.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered
    • 3.1 Nephrology and Urology Devices
    • 3.2 Incontinence Devices
      • 3.2.1 Protective garments for incontinence
      • 3.2.2 Urine Bags
      • 3.2.3 Urinary Catheters
    • 3.3 Renal Dialysis Equipment
      • 3.3.1 Hemodialysis Machines
      • 3.3.2 Peritoneal Dialysis Solutions
      • 3.3.3 Continuous Renal Replacement Therapy Machines
      • 3.3.4 Dialysis Accessories
        • 3.3.4.1 AV Fistula Needles
        • 3.3.4.2 Blood Tubing Sets
        • 3.3.4.3 Dialysis Catheters
        • 3.3.4.4 Dialyzers
    • 3.4 Lithotripters
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
    • 4.4 Japan Healthcare Trade Statistics
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Market Authorization Holder (MAH)
      • 5.1.2 Classification and Pre-Market Approval of Medical Devices
      • 5.1.3 Third Party Certification for Controlled Medical Devices
      • 5.1.4 PMDA Approval for Highly Controlled Medical Devices
      • 5.1.5 Registration Time
      • 5.1.6 Registration Fee
      • 5.1.7 Post Marketing Surveillance
      • 5.1.8 Labeling and Packaging
  • 6 Pricing and Reimbursement
    • 6.1 Market Pricing
    • 6.2 Reimbursement Policies
    • 6.3 Reimbursement Classes
      • 6.3.1 Class A
      • 6.3.2 Class B
      • 6.3.3 Class C
      • 6.3.4 Class F
    • 6.4 Request for Reimbursement
    • 6.5 Reduction in Reimbursement for Medical Devices and Drugs
  • 7 Distribution Structure
  • 8 Nephrology and Urology Devices in Japan
    • 8.1 Nephrology and Urology Devices Cross Country Comparison (2000-2012)
    • 8.2 Nephrology and Urology Devices, Japan, Overall Revenues ($ mn), 2000-2012
    • 8.3 Nephrology and Urology Devices, Japan, Category Volume (Units), 2000-2012
    • 8.4 Nephrology and Urology Devices, Japan Company share (2006-2007)
  • 9 Incontinence Devices in Japan
    • 9.1 Incontinence Devices Overall Revenue (2000-2012)
    • 9.2 Incontinence Devices Overall Volume (2000-2012)
    • 9.3 Incontinence Devices Average Price (2000-2012)
    • 9.4 Incontinence Devices Distribution Share (2006-2007)
    • 9.5 Incontinence Devices, Japan Company share (2006-2007)
  • 10 Lithotripters In Japan
    • 10.1 Lithotripters Overall Revenue (2000-2012)
    • 10.2 Lithotripters Overall Volume (2000-2012)
    • 10.3 Lithotripters Average Price (2000-2012)
    • 10.4 Lithotripters Distribution Share (2006-2007)
    • 10.5 Lithotripters, Japan Company share (2006-2007)
  • 11 Renal Dialysis Equipment In Japan
    • 11.1 Renal Dialysis Equipment Overall Revenue (2000-2012)
      • 11.1.1 Dialysis Accessories, Japan, Revenues by Sub-Segment (2000-2012)
    • 11.2 Renal Dialysis Equipment Overall Volume (2000-2012)
      • 11.2.1 Dialysis Accessories, Japan, Volume by Sub-Segment (2000-2012)
    • 11.3 Renal Dialysis Equipment Average Price (2000-2012)
    • 11.4 Renal Dialysis Equipment Distribution Share (2006-2007)
    • 11.5 Renal Dialysis Equipment, Japan Company share (2006-2007)
  • 12 NIPRO CORPORATION Company Profile
    • 12.1 Company Overview
      • 12.1.1 NIPRO CORPORATION Pipeline Products By Equipment Type
      • 12.1.2 NIPRO CORPORATION Pipeline Products By Development Stage
      • 12.1.3 NIPRO CORPORATION Pipeline Products By Therapy Area
  • 13 Fresenius Medical Care AG & Co. KGaA Company Profile
    • 13.1 Company Overview
    • 13.2 Value Chain Analysis
      • 13.2.1 Manufacturing
        • 13.2.1.1 In House Manufacturing
      • 13.2.2 Product Development
        • 13.2.2.1 Regulatory Approvals
        • 13.2.2.2 Research and Development
      • 13.2.3 Sales and Marketing
        • 13.2.3.1 Partnerships and Alliances
        • 13.2.3.2 Licensing Agreements
  • 14 Gambro AB Company Profile
    • 14.1 Company Overview
    • 14.2 Value Chain Analysis
      • 14.2.1 Manufacturing
        • 14.2.1.1 In House Manufacturing
      • 14.2.2 Product Development
        • 14.2.2.1 Regulatory Approvals
        • 14.2.2.2 Clinical Trials
        • 14.2.2.3 Research and Development
      • 14.2.3 Sales and Marketing
        • 14.2.3.1 Partnerships and Alliances
        • 14.2.3.2 Licensing Agreements
      • 14.2.4 Gambro AB Pipeline Products By Equipment Type
      • 14.2.5 Gambro AB Pipeline Products By Therapy Area
  • 15 Kimberly-Clark Corporation Company Profile
    • 15.1 Company Overview
    • 15.2 Value Chain Analysis
      • 15.2.1 Manufacturing
        • 15.2.1.1 In House Manufacturing
      • 15.2.2 Product Development
        • 15.2.2.1 Regulatory Approvals
        • 15.2.2.2 Research and Development
        • 15.2.2.3 Clinical Trials
      • 15.2.3 Sales and Marketing
        • 15.2.3.1 Licensing Agreements
        • 15.2.3.2 Partnerships and Alliances
  • 16 JMS CO., LTD. Company Profile
    • 16.1 Company Overview
  • 17 Kawamoto Corporation Company Profile
    • 17.1 Company Overview
  • 18 Kawasumi Laboratories, Inc. Company Profile
    • 18.1 Company Overview
      • 18.1.1 Kawasumi Laboratories, Inc. Pipeline Products By Equipment Type
      • 18.1.2 Kawasumi Laboratories, Inc. Pipeline Products by Developmental Stage
      • 18.1.3 Kawasumi Laboratories, Inc. Pipeline Products By Therapy Area
  • 19 NIKKISO CO., LTD. Company Profile
    • 19.1 Company Overview
  • 20 Terumo Corporation Company Profile
    • 20.1 Company Overview
    • 20.2 Value Chain Analysis
      • 20.2.1 Manufacturing
        • 20.2.1.1 In House Manufacturing
      • 20.2.2 Product Development
        • 20.2.2.1 Regulatory Approvals
        • 20.2.2.2 Clinical Trials
        • 20.2.2.3 Research and Development
      • 20.2.3 Sales and Marketing
        • 20.2.3.1 Partnerships and Alliances
        • 20.2.3.2 Licensing Agreements
    • 20.3 Terumo Corporation Pipeline Products
      • 20.3.1 Terumo Corporation Pipeline Products By Equipment Type
      • 20.3.2 Terumo Corporation Pipeline Products By Development Stage
      • 20.3.3 Terumo Corporation Pipeline Products By Therapy Area
      • 20.3.4 Terumo Corporation Pipeline Products By Clinical Trials
      • 20.3.5 Terumo Corporation Pipeline Products By News Summary
  • 21 Unicharm Corporation Company Profile
    • 21.1 Company Overview
  • 22 Appendix
    • 22.1 Global Markets Direct Research Methodology
    • 22.2 Coverage
    • 22.3 Secondary Research
    • 22.4 Primary Research
    • 22.5 Models
    • 22.6 Forecasts
    • 22.7 Expert Panels
    • 22.8 Currency Conversion
    • 22.9 Contact Us
    • 22.10 Disclaimer
  • LIST OF TABLES
  • 1 List of Tables
    • Table 1: Healthcare Expenditure in Japan, 2000 - 2005
    • Table 2: Number of Healthcare Institutions in Japan, 1995 - 2004
    • Table 3: Number of Hospital Beds in Japan, 1995 - 2004
    • Table 4: Number of Medical Personnel in Japan, 1995 - 2004
    • Table 5: Number of Doctors by Specialty in Japan, 2003-2007
    • Table 6: Number of Medical Care Institutions and Beds in Japan, 2000 - 2004
    • Table 7: Japan Healthcare Trade Statistics, 2001-2002
    • Table 8: Registration Processing Time for Medical Devices in Japan, 2007
    • Table 9: Product Registration Fee for Medical Devices in Japan, 2007
    • Table 10: Nephrology and Urology Devices Cross Country Comparison (2000-2012)
    • Table 11: Nephrology and Urology Devices, Japan, Overall Revenues ($ mn), 2000-2012
    • Table 12: Nephrology and Urology Devices, Japan, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 13: Nephrology and Urology Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 14: Nephrology and Urology Devices, Japan, Category Volume (Units), 2000-2012
    • Table 15: Nephrology and Urology Devices, Japan, Category Volume (Units), Historic, 2000-2007
    • Table 16: Nephrology and Urology Devices, Japan, Category Volume (Units), Forecast, 2007-2012
    • Table 17: Nephrology and Urology Devices, Japan Company share by Revenue ($ mn), 2006-2007
    • Table 18: Incontinence Devices, Japan, Revenue ($ mn) by Segment , Historic, 2000-2007
    • Table 19: Incontinence Devices, Japan, Revenue ($ mn) by Segment , Forecast, 2007-2012
    • Table 20: Incontinence Devices, Japan, Overall Volume (Units), Historic, 2000-2007
    • Table 21: Incontinence Devices, Japan, Overall Volume (Units), Forecast, 2007-2012
    • Table 22: Incontinence Devices, Japan, Average Price ($), Historic, 2000-2007
    • Table 23: Incontinence Devices, Japan, Average Price ($), Forecast,, 2007-2012
    • Table 24: Incontinence Devices, Japan, Distribution Share by Revenue, 2006-2007
    • Table 25: Incontinence Devices, Japan Company share by Revenue ($ mn), 2006-2007
    • Table 26: Lithotripters, Japan, Revenue ($ mn) by Segment , Historic, 2000-2007
    • Table 27: Lithotripters, Japan, Revenue ($ mn) by Segment , Forecast, 2007-2012
    • Table 28: Lithotripters, Japan, Overall Volume (Units), Historic, 2000-2007
    • Table 29: Lithotripters, Japan, Overall Volume (Units), Forecast, 2007-2012
    • Table 30: Lithotripters, Japan, Average Price ($), Historic, 2000-2007
    • Table 31: Lithotripters, Japan, Average Price ($), Forecast,, 2007-2012
    • Table 32: Lithotripters, Japan, Distribution Share by Revenue, 2006-2007
    • Table 33: Lithotripters, Japan Company share by Revenue ($ mn), 2006-2007
    • Table 34: Renal Dialysis Equipment, Japan, Revenue ($ mn) by Segment , Historic, 2000-2007
    • Table 35: Renal Dialysis Equipment, Japan, Revenue ($ mn) by Segment , Forecast, 2007-2012
    • Table 36: Dialysis Accessories, Japan, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 37: Dialysis Accessories, Japan, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Table 38: Renal Dialysis Equipment, Japan, Overall Volume (Units), Historic, 2000-2007
    • Table 39: Renal Dialysis Equipment, Japan, Overall Volume (Units), Forecast, 2007-2012
    • Table 40: Dialysis Accessories, Japan, Volume (Units) by Sub-Segment, Historic, 2000-2007
    • Table 41: Dialysis Accessories, Japan, Volume (Units) by Sub-Segment, Forecast,, 2007-2012
    • Table 42: Renal Dialysis Equipment, Japan, Average Price ($), Historic, 2000-2007
    • Table 43: Renal Dialysis Equipment, Japan, Average Price ($), Forecast,, 2007-2012
    • Table 44: Renal Dialysis Equipment, Japan, Distribution Share by Revenue, 2006-2007
    • Table 45: Renal Dialysis Equipment, Japan Company share by Revenue ($ mn), 2006-2007
    • Table 46: NIPRO CORPORATION Pipeline Products by Equipment Type
    • Table 47: NIPRO CORPORATION Pipeline Products by Development Stage
    • Table 48: NIPRO CORPORATION Pipeline Products By Therapy Area
    • Table 49: Gambro AB Pipeline Products by Equipment Type
    • Table 50: Gambro AB Pipeline Products By Development Stage
    • Table 51: Gambro AB Pipeline Products By Therapy Area
    • Table 52: Kawasumi Laboratories, Inc. Pipeline Products by Equipment Type
    • Table 53: Kawasumi Laboratories, Inc. Pipeline Products by Developmental Stage
    • Table 54: Kawasumi Laboratories, Inc. Pipeline Products By Therapy Area
    • Table 55: Terumo Corporation Pipeline Products by Equipment Type
    • Table 56: Terumo Corporation Pipeline Products By Development Stage
    • Table 57: Terumo Corporation Pipeline Products By Therapy Area
    • Table 58: Terumo Corporation Pipeline Products By Clinical Trials
    • Table 59: Terumo Corporation Pipeline Products By News Summaries
    • Table 60: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • LIST OF FIGURES
    • 1.2 List of Figures
    • Figure 1: Healthcare Expenditure in Japan, 2000 - 2005
    • Figure 2: Government and Private Healthcare Expenditure in Japan, 2005
    • Figure 3: Medical Device Classification in Japan, 2007
    • Figure 4: Approval Process for Controlled Medical Devices in Japan, 2007
    • Figure 5: Approval Process for Highly Controlled Medical Devices in Japan, 2007
    • Figure 6: Health Insurance Reimbursement Process in Japan, 2007
    • Figure 7: Distribution Structure for Medical Equipment in Japan, 2007
    • Figure 8: Nephrology and Urology Devices Cross Country Comparison (2000-2012)
    • Figure 9: Nephrology and Urology Devices, Japan, Overall Revenues ($ mn), 2000-2012
    • Figure 10: Nephrology and Urology Devices, Japan, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 11: Nephrology and Urology Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 12: Nephrology and Urology Devices, Japan, Category Volume (Units), 2000-2012
    • Figure 13: Nephrology and Urology Devices, Japan Company share (%), 2007
    • Figure 14: Incontinence Devices, Japan, Revenue ($ mn) by Segment , Historic, 2000-2007
    • Figure 15: Incontinence Devices, Japan, Revenue ($ mn) by Segment , Forecast, 2007-2012
    • Figure 16: Incontinence Devices, Japan, Overall Volume (Units), Historic, 2000-2007
    • Figure 17: Incontinence Devices, Japan, Overall Volume (Units), Forecast, 2007-2012
    • Figure 18: Incontinence Devices, Japan Company share (%), 2007
    • Figure 19: Lithotripters, Japan, Revenue ($ mn) by Segment , Historic, 2000-2007
    • Figure 20: Lithotripters, Japan, Revenue ($ mn) by Segment , Forecast, 2007-2012
    • Figure 21: Lithotripters, Japan, Overall Volume (Units), Historic, 2000-2007
    • Figure 22: Lithotripters, Japan, Overall Volume (Units), Forecast, 2007-2012
    • Figure 23: Lithotripters, Japan Company share (%), 2007
    • Figure 24: Renal Dialysis Equipment, Japan, Revenue ($ mn) by Segment , Historic, 2000-2007
    • Figure 25: Renal Dialysis Equipment, Japan, Revenue ($ mn) by Segment , Forecast, 2007-2012
    • Figure 26: Dialysis Accessories, Japan, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 27: Dialysis Accessories, Japan, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Figure 28: Dialysis Accessories, Japan, Volume (Units) by Sub-Segment, Historic, 2000-2007
    • Figure 29: Dialysis Accessories, Japan, Volume (Units) by Sub-Segment, Forecast,, 2007-2012
    • Figure 30: Renal Dialysis Equipment, Japan Company share (%), 2007
    • Figure 31: Fresenius Medical Care AG & Co. KGaA Value Chain Analysis
    • Figure 32: Gambro AB Value Chain Analysis
    • Figure 33: Kimberly-Clark Corporation Value Chain Analysis
    • Figure 34: Terumo Corporation Value Chain Analysis
    • Figure 35: Global Markets Direct Methodology